Global Cord Blood Corp (CO) Financial Statements
Global Cord Blood Corp (CO) files with the U.S. Securities and Exchange Commission under CIK 0001467808. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2022
- Revenue
- 1.24 billion CNY
- Net Income
- 501.06 million CNY
- Total Assets
- 8.53 billion CNY
- Net Cash from Operations
- 613.61 million CNY
Fiscal year ended Mar 31, 2022. Latest periodic SEC filing: Aug 16, 2022. Source: SEC filings (EDGAR XBRL). Amounts in CNY.
Open the full financial statements for CO in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History